AnnElizabethWoolfreyMD
Pediatric Hematology & Oncology • Seattle, WAProfessor of Medicine, University Wash
Are you Dr. Woolfrey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 38 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000- Is this information wrong?
Summary
- Dr. Ann Woolfrey, MD is a pediatric hematologist/oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington, Connecticut, and Illinois. She is affiliated with Seattle Children's Hospital and is a Professor of Medicine at University Wash.
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 1989 - 1992
University of ChicagoResidency, Internal Medicine/Pediatrics, 1984 - 1988
University of Minnesota Medical SchoolClass of 1984
Certifications & Licensure
WA State Medical License 1989 - 2025
CT State Medical License 1995 - 1997
IL State Medical License 1986 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Start of enrollment: 1999 Dec 01
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders Start of enrollment: 2000 Nov 01
- Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination Wi Start of enrollment: 2000 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsComparison of outcomes of HCT in blast phase of BCR-ABL1(-) MPN with de novo AML and with AML following MDSVikas Gupta, Soyoung Kim, Zhen-Huan Hu, Ying Liu, Mahmoud Aljurf, Ulrike Bacher, Amer Beitinjaneh, Jean-Yves Cahn, Jan Cerny, Edward A. Copelan, Shahinaz M. Gadalla, R...> ;Blood Advances. 2020 Oct 13
- 14 citationsSirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen mismatched donorsBrian Kornblit, Barry E. Storer, Niels Smedegaard Andersen, Michael B. Maris, Thomas R. Chauncey, Effie W. Petersdorf, Ann E. Woolfrey, Mary Ed Flowers, Rainer Storb, ...> ;Blood. 2020 Sep 24
- 20 citationsAllogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.Jason P. Cooper, Barry E. Storer, Noa Granot, Boglarka Gyurkocza, Mohamed L. Sorror, Thomas R. Chauncey, Judith A. Shizuru, Georg Franke, Michael B. Maris, Michael Boy...> ;Haematologica. 2020 Jun 4
- Join now to see all
Press Mentions
- Strategies to Successfully Manage Complex Cell Therapy Clinical TrialsFebruary 10th, 2023
Cellular Immunotherapies for Leukemia PatientsJanuary 10th, 2017
Grant Support
- Hematopoietic Cell Transplant: Platform For Purging The Latent HIV ReservoirNational Institute Of Allergy And Infectious Diseases2011
- Developmental Regulation Of HLA DQ GenesNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
- Developmental Regulation Of HLA DQ GenesNational Institute Of Diabetes And Digestive And Kidney Diseases1995
Hospital Affiliations
Seattle Children's HospitalSeattle, Washington
